2019 Hematology Market: Supplier Shares, Strategic Assessments of Current and Emerging Competitors
The report presents strategic analyses of the major current and emerging suppliers in terms of their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
- Abbott
- Agilent Technologies
- Beckman Coulter/Danaher
- Becton Dickinson
- Bio-Rad
- CellaVision
- Horiba
- Iris Diagnostics/Danaher
- Nihon Kohden
- Ortho-Clinical Diagnostics
- Roche
- Siemens
- Sysmex
2020 Global Nucleic Acid Testing/NAT Market, 2019-2023: Emerging Opportunities in US, Europe, Japan--Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
This new seven-country study contains 1,398 pages, 194 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular
USD 24500 View Report2024 Global Nucleic Acid Testing/NAT Market, 2019-2023: Emerging Opportunities in US, Europe, Japan--Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
This new seven-country study contains 1,398 pages, 194 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular
USD 24500 View Report2022 World Hematology Market: Supplier Shares in 28 Countries--Competitive Analysis of Leading and Emerging Market Players
This new report provides hematology market shares for the following countries: Argentina, Bolivia, Brazil, Canada, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, El Salvador, France, Germany, Guatemala, Haiti, Italy, Jamaica,
USD 3500 View ReportNAT and Immunohematology Market: Supplier Sales and Shares by Country, Innovative Technologies and Market Applications
The report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive
USD 2850 View ReportFill The Form For Sample Request